Table 3:

Demographics of patients initiated on HCV interferon-free DAA therapy (August 2016–August 2017)

Patients (n = 51)	No.* (%)
Mean age, years	52
Male	42 (82)
Active drug use	32 (63)
Heroin	22 (69)
Cocaine	17 (53)
Other	11 (34)
Opioid overdose	2 (4)
Opioid overdose deaths	0 (—)
HCV genotype
1a	33 (65)
1b	1 (2)
2	5 (10)
3	12 (23)

*Unless otherwise specified

DAA = Directly acting antiviral; HCV = Hepatitis C virus